US Patent Issued to Cornell University on Aug. 26 for "DARC expression as prognosticator of immunotherapy outcomes" (New York Inventor)

ALEXANDRIA, Va., Aug. 26 -- United States Patent no. 12,398,428, issued on Aug. 26, was assigned to Cornell University (Ithaca, N.Y.).

"DARC expression as prognosticator of immunotherapy outcomes" was invented by Melissa B. Davis (New York).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods for prognosticating if an individual afflicted with a malignant tumor is likely to respond favorably to immunotherapy comprising testing for the presence or absence of DARC expression in the tumor, and if no DARC expression is detected, identifying the individual as not being suitable for immunotherapy, and optionally administering an anti-cancer therapy other than immunotherapy to the individual, or if DARC expression...